Ultra-rapid thrombolysis hadn’t been well studied in the context of emergent large vessel occlusions. Now a retrospective study finds its outcome benefits extend to this substantial stroke subgroup.
Findings from the first study to examine the importance of treating in the “golden hour” specifically in the setting of ELVO strokes could reshape thinking around ELVO management.
The answer is yes, according to a new national database analysis, but the differences are limited and fairly focused on promptness of reperfusion therapy.
Something’s going right in acute stroke therapy: Medicare data show that one-year mortality fell 18 percent from 2009 to 2013 in tandem with a 60 percent rise in IV tPA use.
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services Policy
A slew of randomized trials have confirmed the superiority of endovascular therapy over IV t-PA alone for acute ischemic stroke. Here’s how endovascular therapies can be best deployed to yield the greatest patient benefits.
A major study from the Netherlands has demonstrated the effectiveness of using endovascular therapy to treat patients with acute ischemic stroke caused by intracranial arterial occlusion.